PharmiWeb.com - Global Pharma News & Resources
13-Feb-2019

Drugs targeting metastatic cancers, opioid addiction are among additional specialty drugs available through AllianceRx Walgreens Prime

ORLANDO, Fla., Feb. 13, 2019 /PRNewswire/ -- AllianceRx Walgreens Prime, a leading central specialty and home delivery pharmacy, can now offer new medicines to patients with certain rare, chronic and complex conditions.

Known as limited distribution drugs, these hard-to-find medicines treat rare conditions such as advanced cancer of the stomach, community-acquired bacterial pneumonia (CABP), and opioid addiction, to name a few.

They include:

  • Cyramza® (ramucirumab) is used alone or in combination with various types of chemotherapy to treat patients with specific kinds of advanced cancers – including cancer of the stomach, metastatic (cancer that has spread to other parts of the body) non-small cell lung cancer (NSCLC) or metastatic colorectal cancer – and whose cancer has progressed on or after being treated with other initial types of chemotherapy. Cyramza is manufactured by Lilly.
  • Nuzyra™ (omadacycline) is indicated for the treatment of adult patients with the following indications caused by susceptible microorganisms: community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI). Nuzyra is marketed by Paratek Pharmaceuticals, Inc.
  • Probuphine® (buprenorphine) is a subdermal (under the skin) implant manufactured by Titan Pharmaceuticals. The implant treats certain adults who are addicted to opioid drugs by providing non-fluctuating blood levels of buprenorphine around the clock for a period of six months, following a single treatment surgical procedure.
  • Portrazza™ (necitumumab), manufactured by Lilly, is a first-line treatment of patients with metastatic squamous NSCLC.
  • Ultomiris™ (ravulizumab-cwvz) is prescribed for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria, a rare and life-threatening blood disease. Alexion Pharmaceuticals manufacturers the medicine.

"We're pleased that these manufacturers have chosen AllianceRx Walgreens Prime as a limited distribution drug partner for patients, families, communities and providers," says Tracey James, RPh, AllianceRx Walgreens Prime vice president of pharmacy services. "We're committed to delivering the high-quality care, support and expertise necessary to deliver better health outcomes and cost savings to our patients."

In addition, AllianceRx Walgreens Prime can dispense two recently authorized generic drugs of Epclusa® (sofosbuvir/velpatasvir) and Harvoni® (ledipasvir/sofosbuvir) to patients. Manufactured by Gilead, both medicines are highly utilized for the treatment of hepatitis C virus. 

About AllianceRx Walgreens Prime
AllianceRx Walgreens Prime (alliancerxwp.com) is a specialty and home delivery pharmacy that strives to provide exceptional care throughout a patient's treatment journey with the medications they need every day. Formed in 2017 through a collaboration between Walgreens, one of the nation's largest chain drug stores, and Prime Therapeutics, a leading pharmacy benefit manager, the company offers tools and resources for patients, providers and health plans to deliver the optimal health outcomes. The company is headquartered in Orlando, Fla. and its pharmacies are accredited by several national pharmacy accreditation services.

Media Contact
Adrienne Foley | adrienne.foley@alliancerxwp.com | 612.777.6259

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/drugs-targeting-metastatic-cancers-opioid-addiction-are-among-additional-specialty-drugs-available-through-alliancerx-walgreens-prime-300794554.html

SOURCE AllianceRx Walgreens Prime

Editor Details

Last Updated: 13-Feb-2019